Beijing Renzhong Pharmaceutical Co., Ltd.

Study on the single oral administration of test preparation Bripipiprazole Tablets (Beijing Renzhong Pharmaceutical Co., Ltd., specification: 2 mg) and reference preparation Bripipiprazole Tablets (trade name: Rexulti®; manufactured by Otsuka) to healthy subjects after a meal Co., Ltd., specification: 2 mg), whether there is any difference in the degree and speed of absorption, evaluate the bioequivalence of the test preparation and the reference preparation when administered in the postprandial state, and observe the health effects of the test preparation and the reference preparation. Safety in subjects

Study healthy subjects taking a single fasting oral administration of the test preparation Bripipiprazole Tablets (Beijing Renzhong Pharmaceutical Co., Ltd., specification: 2 mg) and the reference preparation Bripipiprazole Tablets (trade name: Rexulti®; Otsuka Manufacturing Co., Ltd. Co., Ltd., specification: 2mg), whether there is any difference in the extent and speed of absorption, evaluate the bioequivalence of the test preparation and the reference preparation when administered in the fasting state, and observe the effects of the test preparation and the reference preparation on healthy subjects safety among